Assembly Biosciences
ASMB
30 hedge funds and large institutions have $15.5M invested in Assembly Biosciences in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
11% more funds holding
Funds holding: 27 → 30 (+3)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
4% less capital invested
Capital invested by funds: $16.1M → $15.5M (-$570K)
2.87% less ownership
Funds ownership: 19.05% → 16.17% (-2.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$278K |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$194K |
| 3 |
AI
Acuitas Investments
Seattle,
Washington
|
+$188K |
| 4 |
Renaissance Technologies
New York
|
+$163K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$55.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.74M |
| 2 |
Millennium Management
New York
|
-$1.31M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$112K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$25.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$23.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
RhumbLine Advisers
Boston,
Massachusetts
| $2.88K | – | – | – |
|
27
Osaic Holdings
Scottsdale,
Arizona
| $2.83K | +$2.85K | +187 | New |
|
28
Lazard Asset Management
New York
| $1K | +$1.08K | +71 | New |
|
|
EWA
29
EverSource Wealth Advisors
Birmingham,
Alabama
| $833 | – | – | – |
|
|
FFA
30
Frazier Financial Advisors
Columbus,
Ohio
| $16 | – | – | – |
|
31
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$41 | -3 | Closed |
|
ASMB Hedge Fund Activity: Q3 2024 in Review
30 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q3 2024, worth a combined $15.5M — down 3.5% from $16.1M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ASMB positions and 1 closed out — a net gain of 3 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Northern Trust, adding an estimated $278K. The largest seller was Armistice Capital, cutting an estimated $1.74M.
- 30 institutional investors held Assembly Biosciences (ASMB) as of Q3 2024, up from 27 in Q2 2024.
- Funds reported $15.5M of Assembly Biosciences stock for Q3 2024, down 3.5% quarter-over-quarter.
- 4 funds opened new Assembly Biosciences positions in Q3 2024 and 1 closed out, a net change of +3 holders.
- The largest Assembly Biosciences buyer in Q3 2024 was Northern Trust, an estimated $278K added.
- The largest Assembly Biosciences seller in Q3 2024 was Armistice Capital, an estimated $1.74M sold.
Based on aggregated 13F filings for Q3 2024.